Quantcast

Latest cancer therapies Stories

2010-04-20 04:35:00

DALLAS, April 20, 2010 /PRNewswire/ -- - ReportsandReports Announce it Will Carry Pipeline Insight: Small Molecule Targeted Cancer Therapies - New targets set to drive growth Market Research Report in its Store. Browse the complete Report on: http://www.reportsandreports.com/market-reports/pipeline-insight-small-molecu le-targeted-cancer-therapies-new-/ (Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL...

2010-03-02 08:38:00

THE WOODLANDS, Texas, March 2 /PRNewswire/ -- In only its second year as an Affiliate Member of Radiation Therapy Oncology Group (RTOG), US Oncology, Inc. announced today that its wholly-owned subsidiary US Oncology Research, LLC placed second amongst all affiliate members in patients accrued to RTOG clinical trials. US Oncology is the nation's leading oncology services company uniting the nation's largest cancer treatment and research network to expand patient access to high-quality,...

2010-03-01 05:05:00

BOTHELL, WA and VANCOUVER, March 1 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI), announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the effectiveness of cancer therapies. Researchers...

2010-02-18 07:00:00

WALTHAM, Mass., Feb. 18 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the targeted cancer drug market will double in value, from $25 billion in 2008 to $51 billion in 2015. Growth will be driven by increasing sales of existing marketed targeted agents and by sales of new targeted agents introduced to the market prior to the end of 2015. In 2008, the major players in the targeted cancer...

2010-01-07 06:00:00

PRINCETON, N.J., Jan. 7 /PRNewswire/ -- Sopherion Therapeutics, LLC, a biopharmaceutical company focused on the development and commercialization of anti-cancer therapies, announced today that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for nonpegylated liposomal doxorubicin (Myocet(TM)) for first-line therapy of HER2 positive metastatic breast cancer. Treatment with Myocet(TM) has already shown a reduced level of cardiotoxicity as compared to...

2009-11-25 06:30:00

NEW YORK, Nov. 25 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Cancer Therapies - Global Market Opportunities http://www.reportlinker.com/p0164250/Cancer-Therapies---Global-Market-Opportunities.html Cancer therapies are geared towards controlling the growth of cancerous tumors, and preventing the spread of cancer to other organs of the body. Cancer care is becoming a prime concern among national health authorities, in both...

2009-10-14 11:43:52

Women with breast cancer reduced stress and improved their mental health and emotional well being through the Transcendental Meditation technique, according to a new study published in the current issue of the peer-reviewed Integrative Cancer Therapies (Vol. 8, No. 3: September 2009). "A Randomized Controlled Trial of the Effects of Transcendental Meditation on Quality of Life in Older Breast Cancer Patients" was a collaboration between the Center for Healthy Aging at Saint Joseph Hospital;...

2009-09-10 07:46:00

NEW YORK, Sept. 10 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. World Cancer Therapies Market http://www.reportlinker.com/p0109886/World-Cancer-Therapies-Market.html This report analyzes the global market for Cancer Therapies in US$ Billion. The specific product segments analyzed are Chemotherapy, Targeted Therapy, Hormonal Therapy, and Immunotherapy. Annual forecasts for the global market is provided for the period of 2006...

2009-09-02 14:34:00

Scientists identify new target for cancer cure Researchers Dr. Marc Therrien at the Institute for Research in Immunology and Cancer (IRIC) of the Universit© de Montr©al, and Dr. Frank Sicheri, at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital in Toronto, have discovered a new target that may be instrumental in the development of new, more effective cancer therapies. A recent article co-authored by Drs. Therrien and Sicheri and published in the leading scientific...

2009-08-13 12:28:55

A multi-institutional team of Boston-area researchers has discovered a chemical that works in mice to kill the rare but aggressive cells within breast cancers that have the ability to seed new tumors.These cells, known as cancer stem cells, are thought to enable cancers to spread "” and to reemerge after seemingly successful treatment. Although further work is needed to determine whether this specific chemical holds therapeutic promise for humans, the study shows that it is possible to...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related